Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137231000087116 | BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 21821000087117 | BCG Vaccine SP | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 21841000087114 | BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 73031000087113 | BCG vaccin BCG SP | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | Bacillus Calmette-Guerin antigen | true | Inferred relationship | Some | 1 | |
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | Has supplier | Sanofi Pasteur Limited (supplier) | true | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | BCG Bacillus Calmette Guerin unspecified | true | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | Bacillus Calmette-Guerin antigen-containing product | false | Inferred relationship | Some | ||
| BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | bacille de Calmette-Guérin atténué | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Historical name codes for vaccines reference set (foundation metadata concept)
FHIR